Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19
Clinical trial NCT05184127 · COMPLETED
Trial details
- NCT number
- NCT05184127
- Sponsor
- National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2021-09-07
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.